Greater Cannabis Company (GCAN) EBITDA (2017 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly EBITDA of -$33376.0 in Q1 2026, up 37.97% quarter-over-quarter from -$53806.0 in Q4 2025, and up 23.34% on a YoY basis from -$27060.8 in Q1 2025.
Greater Cannabis Company (GCAN) EBITDA (2017 - 2026) Analysis & Trends
Greater Cannabis Company's EBITDA history runs 10 years deep, the most recent figure standing at -$33376.0 for Q1 2026.
- In Q1 2026, EBITDA rose 23.34% year-over-year to -$33376.0; the TTM figure through Mar 2026 stood at -$172845.0 (down 7.45% YoY), while the FY2025 annual figure was -$183005.0, down 17.1% from the prior year.
- EBITDA was -$33376.0 for Q1 2026 at Greater Cannabis Company, up from -$53806.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$33376.0 in Q1 2026 to a low of -$53806.0 in Q4 2025.
- Historically, EBITDA has averaged -$42650.4 across 5 years, with a median of -$42267.0 in 2022.
- The sharpest annual moves came in 2022 and 2025: EBITDA soared 64.81% in 2022, then slumped 43.01% in 2025.
- A 5-year view of EBITDA shows it stood at -$42267.0 in 2022, then fell by 4.16% to -$44027.0 in 2023, then rose by 14.54% to -$37625.0 in 2024, then plunged by 43.01% to -$53806.0 in 2025, then soared by 37.97% to -$33376.0 in 2026.
- The last three EBITDA figures came in at -$33376.0 (Q1 2026), -$53806.0 (Q4 2025), and -$37412.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -98.81 Mn |
| 10 | Greater Cannabis Company | - | - | - | -33,376.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33,376.00 |
| Dec 31, 2025 | -53,806.00 |
| Sep 30, 2025 | -37,412.00 |
| Jun 30, 2025 | -48,251.00 |
| Mar 31, 2025 | -43,536.00 |
| Dec 31, 2024 | -37,625.00 |
| Sep 30, 2024 | -40,443.00 |
| Jun 30, 2024 | -39,257.00 |
| Mar 31, 2024 | -38,951.00 |
| Dec 31, 2023 | -44,027.00 |
| Sep 30, 2023 | -50,465.00 |
| Jun 30, 2023 | -41,404.00 |
| Mar 31, 2023 | -39,468.00 |
| Dec 31, 2022 | -42,267.00 |
| Sep 30, 2022 | -49,304.00 |
| Jun 30, 2022 | -43,034.00 |
| Mar 31, 2022 | -42,430.00 |
| Dec 31, 2021 | -120,102.00 |
| Sep 30, 2021 | -74,338.00 |
| Jun 30, 2021 | -62,474.00 |